Mostrando 10 resultados de: 18
Filtros aplicados
Publisher
International Journal of Cardiology(2)
New England Journal of Medicine(2)
The Lancet(2)
The Lancet Global Health(2)
American Heart Journal(1)
Área temáticas
Enfermedades(13)
Medicina y salud(10)
Problemas sociales y servicios a grupos(7)
Farmacología y terapéutica(5)
Fisiología humana(4)
Association of urinary sodium excretion with blood pressure and cardiovascular clinical events in 17,033 Latin americans
ArticleAbstract: BACKGROUND Information on actual sodium intake and its relationships with blood pressure (BP) and clPalabras claves:Blood pressure, Cardiovascular disease, Hypertension, Mortality , Sodium intakeAutores:Avezum A.J., Camacho-López P.A., DIaz R., Lamelas P.M., Lanas F., Mente A., Oliveira G.B.F., Orlandini A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Seron P., Teo K.K., Yusuf S.Fuentes:googlescopusAssociations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies
ArticleAbstract: Background Several studies reported a U-shaped association between urinary sodium excretion and cardPalabras claves:Autores:Anand S.S., Avezum A.J., Bahonar A., Chifamba J., Dagenais G.R., DIaz R., Iqbal R., Lanas F., Lear S.A., Li W., Lu Y., Mann J.F.E., McQueen M.J., Mente A., Mony P.K., Oguz A., O’Donnell M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Rensheng L., Rosengren A., Schutte A.E., Szuba A., Teo K.K., Yi S., Yusoff K., Yusuf R., Yusuf S., Yusufali A.M.Fuentes:googlescopusAtherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)
ArticleAbstract: This is an executive summary made by a group of experts named Latin American Academy for the study oPalabras claves:Autores:Acevedo M., Alonso R., Arocha I., Bryce A., Carlos Ernesto Peñaherrera, Carrera C., Chirinos J.A., Cobos L., Colan J., Gómez-Alvares E., Gómez-M J.R., Isea-Perez J.E., Lanas F., Lara J., Lorenzatti A.J., Lozada A.F., Machado-H L.T., Medina J., Medina-Palomin F., Merchan-V A., Morales E., Paniagua M., PATRICIO LOPEZ -JARAMILLO, Pinto X., Piskorz D.L., Ponte-Negretti C.I., Ullauri V.E., Varleta P., Villar-M R.A., Wyss-Q F.S.Fuentes:scopusCorrigendum to "heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)" (Am Heart J. (2015) 170:4 (627-634))
OtherAbstract:Palabras claves:Autores:Alhabib K.F., Badr A., Belley-Cote E.P., Damasceno A., Dokainish H., Elmaghawry M., ElSayed A., Grinvalds A., Harkness K., Huffman M.D., Karaye K.M., Lanas F., McKelvie R., Mondo C.K., Orlandini A., Palileo-Villaneuva L., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Roy A., Sliwa K., Teo K.K., Yusoff K., Yusuf S., Zhu J.Fuentes:scopusDesign and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide
ArticleAbstract: The aim was to determine the effects of dulaglutide, a synthetic once-weekly, injectable human glucaPalabras claves:antidiabetic drug, Cardiovascular disease, Clinical trial, diabetes complications, GLP-1 receptor agonistAutores:Atisso C.M., Avezum A.J., Basile J.N., Cardona-Munoz E.G., Chung N., Colhoun H.M., Conget I., Cushman W.C., Dagenais G.R., DIaz R., Franek E., Gerstein H.C., Hâncu N., Hanefeld M., Holt S., Jansky P., Keltai M., Lakshmanan M., Lanas F., Leiter L.A., Pais P., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu W.H.H., Temelkova-Kurktschiev T., Xavier D.Fuentes:scopusGlobal mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study
ArticleAbstract: Background Most data on mortality and prognostic factors in patients with heart failure come from NoPalabras claves:Autores:Abdullah A., Ai F., Alhabib K.F., Anaya M.B., Badr A., Bai X., Balasubramanian K., Bangdiwala S.I., Belley-Cote E.P., Bhardwaj A.K., Bourke P., Campos R., Chacón C., Chaturvedi V., Chen X., Chen Y., Cursack G., Damasceno A., de Salazar D.I.M., Diez F., Dokainish H., Elmaghawry M., ElSayed A., Escobar C., Freddy O. Trujillo Cruz, Gao M., Garcia C., Ge C., Gokhale G.K., Gomez E., Grinvalds A., Gupta R., Harkness K., Hassan M.R.A., He Y., HOMINAL M.A., Honnutagi R., Huang W., Huffman M.D., Ingaramo A., Islam S., Jaramillo M.L., Jiang H., Joshi P., Karaye K.M., Kucharczuk G., Ladhani S., Lanas F., Lanas F.T., León M.B., Liang T., Liang X., Liao Y., Liu S., Lu L., Luo Y., McKelvie R., Mendoza J.L.A., Mondo C.K., Montalvo L.A.F., Nahuelpan L., Navas A.T., Negi P.C., Olivares C., Orlandini A., Palileo-Villaneuva L., Patiño E.P., PATRICIO LOPEZ -JARAMILLO, Pelliza M., Perugachi C., Prabhakaran D., Qin S., Quiroz F., Reddy N., Riquelme R., Rodríguez M.J., Rojas A., Roy A., Sliwa K., Sotomayor M.S., Tan G., Tan H., Teo K.K., Tibazarwa K., Vilamajo O.G., Villani A., Wagdy K., Wang T., Wang X., Wei F., Xiao F., Yacoub M.H., Yusoff K., Yusuf S., Zapata G., Zhang B., Zheng T., Zhu J.Fuentes:scopusNovel Indices of Cognitive Impairment and Incident Cardiovascular Outcomes in the REWIND Trial
ArticleAbstract: Context: Low cognitive scores are risk factors for cardiovascular outcomes. Whether this relationshiPalabras claves:cardiovascular events, cognitive impairment, Composite outcome, death, Geometric mean, MACE, risk factor, strokeAutores:Angelyn Bethel M., Basile J.N., Cardona-Munoz E.G., Conget I., Cukierman-Yaffee T., Dagenais G.R., Franek E., Gerstein H.C., Hall S., Hâncu N., Jansky P., Lakshmanan M., Lanas F., Leiter L.A., PATRICIO LOPEZ -JARAMILLO, Pirags V., Pogosova N., Probstfield J.L., Ramasundarahettige C., Rao-Melacini P., Raubenheimer P.J., Riddle M.C., Rydén L.E., Shaw J.E., Sheu H.H., Temelkova-Kurktschiev T.Fuentes:googlescopusHeart Failure in Africa, Asia, the Middle East and South America: The INTER-CHF study
ArticleAbstract: Background There are few data on heart failure (HF) patients from Africa, Asia, the Middle East andPalabras claves:epidemiology, Global Health, Heart Failure, registryAutores:Alhabib K.F., Badr A., Balasubramanian K., Belley-Cote E.P., Damasceno A., Dokainish H., Elmaghawry M., ElSayed A., Grinvalds A., Harkness K., Huffman M.D., Karaye K.M., Lanas F., McKelvie R., Mondo C.K., Orlandini A., Palileo-Villaneuva L., PATRICIO LOPEZ -JARAMILLO, Prabhakaran D., Roy A., Sliwa K., Teo K.K., Tibazarwa K., Yacoub M.H., Yusoff K., Yusuf S., Zhu J.Fuentes:googlescopusInequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study
ArticleAbstract: Background: There is little evidence on the use of secondary prevention medicines for cardiovascularPalabras claves:Autores:Alhabib K.F., Avezum A.J., Bai X., Chifamba J., Chow C.K., Corsi D.J., Dagenais G.R., Dans A.M., DIaz R., Erbakan A.N., Iqbal R., Kelishadi R., Khatib R., Lanas F., Lear S.A., Li W., Liu J., Mckee M., Mohan V., Monsef N., Mony P.K., Murphy A., Noorhassim I., O'Donnell O., Palafox B., PATRICIO LOPEZ -JARAMILLO, Perel P., Puoane T., Rangarajan S., Rosengren A., Schutte A.E., Sintaha M., Stuckler D., Teo K.K., Wielgosz A., Yeates K.E., Yin L., Yusoff K., Yusuf S., Zatońska K.Fuentes:googlescopusLong-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial
ArticleAbstract: Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or peripheralPalabras claves:aspirin, Coronary artery disease, Peripheral artery disease, rivaroxabanAutores:Aboyans V., Alings M., Anand S.S., Avezum A.J., Bangdiwala S.I., Bhatt D.L., Bosch J.J., Branch K.R.H., Camillo Felix, Commerford P.J., Connolly S.J., Dagenais G.R., Dans A.L., DIaz R., Eikelboom J.W., Ertl G., Fox K.A.A., Guzik T.J., Hori M., Ibrahim K.S., Kakkar A.K., Keltai K., Keltai M., Kim J.H., Lamy A., Lanas F., Leong D.P., Lewis B.S., Liang Y., Lonn E.M., Lopez-Jaramillo P., Maggioni A.P., Metsarinne K.P., Muehlhofer E., Neumann C., O’Donnell M., Parkhomenko A.N., Piegas L.S., Pogosova N., Probstfield J.L., Rydén L.E., Sharma M., Steg P.G., Stoerk S., Tasto C., Tonkin A.M., Torp-Pedersen C., Tyrwitt J., Vanassche T., Varigos J.D., Verhamme P.B., Vinereanu D., Widimsky P., Yusuf S., Zhu J.Fuentes:scopus